Posts

Hedge funds, pharma patents and thorny issues: a word on IPRs following Lialda

Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra dispute

Letter from AmeriKat: Samsung sets sights on Apple Supreme Court fight, Bass's hedge fund model up to bat and Mr Softee takes aim